Reference
Health Canada. Summary Safety Review - AVONEX (interferon beta-1a) - Assessing the Potential Risk of an Inflammatory Disease that Affects One or More Organs (Sarcoidosis). Internet Document : 8 Jan 2018. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/avonex-assessing-potential-risk-inflammatory-disease-affects-organs.html
Rights and permissions
About this article
Cite this article
Health Canada: no risk of sarcoidosis with Avonex. Reactions Weekly 1685, 1 (2018). https://doi.org/10.1007/s40278-018-40860-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-40860-7